Stocktoria
Penumbra Inc PEN
NYSE · XNYS · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2015-09-18
Penumbra Inc financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $1.4B | $1.2B | $1.1B | $847.1M | $747.6M |
| Gross profit | $942.4M | $755.0M | $682.6M | $535.2M | $475.4M |
| SG&A expense | $663.4M | $574.0M | $506.5M | $449.7M | $378.3M |
| Operating income | $189.2M | $9.3M | $73.6M | $6.1M | -$7.5M |
| Interest expense | — | — | $1.7M | $1.7M | $1.9M |
| Income tax | $27.4M | $6.9M | -$11.3M | $5.9M | -$13.1M |
| Net income | $177.7M | $14.0M | $91.0M | -$2.0M | $5.3M |
| EPS (diluted) | $4.52 | $0.36 | $2.32 | $-0.05 | $0.14 |
| Operating cash flow | $238.7M | $168.5M | $97.3M | -$55.7M | $9.5M |
| Free cash flow | $174.9M | $147.3M | $82.1M | -$75.0M | -$11.7M |
| Cash & equivalents | $186.9M | $324.4M | $167.5M | $69.9M | $59.4M |
| Inventory | $431.5M | $406.7M | $388.0M | $334.0M | $263.5M |
| Total assets | $1.8B | $1.5B | $1.6B | $1.4B | $1.2B |
| Total liabilities | $398.9M | $382.2M | $377.4M | $372.0M | $290.3M |
| Shareholders' equity | $1.4B | $1.2B | $1.2B | $998.9M | $953.9M |
Source: SEC EDGAR filings · CIK 0001321732 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.